TheScientist.com - Magazine of the Life Sciences, Every Day, Online
  Please Login or Register
  • Home
  • Community
  • Current Issue
  • Browse Archive
  • Careers
  • Video & Multimedia
  • Subscribe

Front Cover
Advertisement
Front Cover
Supplements
  • Life Sciences in
    the Greater
    Phila. Region
  • Schizophrenia
  • NC: State of the Life Sciences
  • Autoimmunity


Survey Series
  • Best Places to Work
  • $alary $urvey
  • Lab Web Site and
    Video Awards

The Scientist Daily
  • Science headlines delivered daily.
    Register today.

For Advertisers
  • Advertise with Us
  • Contact Ad Team
  • 2009 Media Kit



by Pat Hagan

RESEARCH ROUND-UP

Back to the drawing board for CJD treatment

Email: Pat Hagan - phagan@btinternet.com
News from The Scientist 2001, 2(1):20011207-03

Published 7 December 2001

LONDON — National newspapers and TV like nothing better than a 'miracle cure'. And the story last summer of a young British woman who appeared to make an astonishing recovery from variant Creutzfeldt Jakob Disease (CJD), after being the first human guinea pig to try a new drug treatment (quinacrine and chlorpromazine), had all the right ingredients for the journalistic frenzy that followed.


 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Subscribing to The Scientist is easy and inexpensive.

 

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.

 
  Not yet registered? Get free access  
 

The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study.
Recommend The Scientist today

 



About TS | Contact | Advertise | Editorial Advisory Board | Privacy Policy
© 1986-2008 The Scientist